CN103243072B - CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 - Google Patents
CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 Download PDFInfo
- Publication number
- CN103243072B CN103243072B CN201310173235.6A CN201310173235A CN103243072B CN 103243072 B CN103243072 B CN 103243072B CN 201310173235 A CN201310173235 A CN 201310173235A CN 103243072 B CN103243072 B CN 103243072B
- Authority
- CN
- China
- Prior art keywords
- interleukin
- cell
- fragment
- mixture
- lymphocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173235.6A CN103243072B (zh) | 2013-05-09 | 2013-05-09 | CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173235.6A CN103243072B (zh) | 2013-05-09 | 2013-05-09 | CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103243072A CN103243072A (zh) | 2013-08-14 |
CN103243072B true CN103243072B (zh) | 2016-03-02 |
Family
ID=48922951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310173235.6A Active CN103243072B (zh) | 2013-05-09 | 2013-05-09 | CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103243072B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112080467A (zh) * | 2014-03-20 | 2020-12-15 | H.李莫菲特癌症中心研究院 | 用于过继细胞疗法的肿瘤浸润淋巴细胞 |
CN105985931A (zh) * | 2016-06-21 | 2016-10-05 | 黑龙江天晴干细胞股份有限公司 | 一种nk细胞体外扩增组合物及nk细胞扩增方法 |
CN117645669A (zh) * | 2022-08-29 | 2024-03-05 | 星奕昂(上海)生物科技有限公司 | 具有膜结合型il-21的免疫细胞及其制法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154207B (zh) * | 2011-03-28 | 2013-02-13 | 浙江中赢干细胞生物工程股份有限公司 | CD8α-白介素21-CD137复合物扩增激活淋巴细胞的方法 |
CN102586185A (zh) * | 2012-03-12 | 2012-07-18 | 浙江中赢方舟生物工程股份有限公司 | 一种k562细胞扩增激活nk细胞的方法 |
-
2013
- 2013-05-09 CN CN201310173235.6A patent/CN103243072B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103243072A (zh) | 2013-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sun et al. | Activating a collaborative innate-adaptive immune response to control metastasis | |
CN103232973B (zh) | 一种k562细胞扩增激活nk细胞的方法 | |
Tonn et al. | Treatment of patients with advanced cancer with the natural killer cell line NK-92 | |
Li et al. | Roles of myeloid-derived suppressor cell subpopulations in autoimmune arthritis | |
Kang et al. | Systematic exposition of mesenchymal stem cell for inflammatory bowel disease and its associated colorectal cancer | |
CN111989118A (zh) | 包含耗竭性抗cd4单克隆抗体的抗癌t细胞治疗剂辅助用组合物及其用途 | |
AU2011351445A1 (en) | SiRNA against Cbl-b and optionally IL2 und IL12 for use in the treatment of cancer | |
Samadani et al. | CAR T-cells profiling in carcinogenesis and tumorigenesis: an overview of CAR T-cells cancer therapy | |
Knedla et al. | Developments in the synovial biology field 2006 | |
CN103243072B (zh) | CD8α-白介素21片段-CD137复合物扩增激活淋巴细胞的方法 | |
CN102154207B (zh) | CD8α-白介素21-CD137复合物扩增激活淋巴细胞的方法 | |
CN110016465A (zh) | 一种包含b细胞及肿瘤双识别性t细胞的免疫细胞药物 | |
KR101299299B1 (ko) | 암면역 요법용 세포의 제조방법 | |
Lou et al. | Retinoic acid inhibits tumor-associated mesenchymal stromal cell transformation in melanoma | |
CN105254744B (zh) | 多肽xzz-5的异源表达及其在增强cik细胞杀瘤活性中的应用 | |
CN109439627A (zh) | 一种极化和扩增cd4+t细胞的方法及组合物及在治愈表达特异性抗原的肿瘤中的应用 | |
US20160340650A1 (en) | Blood derived immune stimulatory compositions | |
JP5301994B2 (ja) | Lak細胞の増殖方法 | |
CN105647863B (zh) | 一种无胎牛血清扩增激活lak细胞的方法 | |
CN114222814A (zh) | 具有比人外周血的自然杀伤细胞更高水平的自然细胞毒性受体、杀伤活性及γ-干扰素生产能力的记忆样自然杀伤细胞的制备方法 | |
CN115944650B (zh) | 肿瘤浸润细胞在制备抗肿瘤药物中的应用及模型构建方法 | |
Klingemann | Cellular therapy of cancer with natural killer cells: will it ever work? | |
CN105585637B (zh) | 基于il-12稳定膜表达的肿瘤治疗剂及其制法和用途 | |
CN109913413B (zh) | 一种加载pd-1抗体的t细胞体外培养方法、其细胞制剂及其应用 | |
CN114921443B (zh) | 肺炎链球菌肽链内切酶o在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU ZHONGYING TECHNOLOGY GROUP CO., LTD. Free format text: FORMER OWNER: ZHEJIANG ZHONGYING LIFE ARK BIOTECHNOLOGICAL ENGINEERING CO., LTD. Effective date: 20130830 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310000 HANGZHOU, ZHEJIANG PROVINCE TO: 310052 HANGZHOU, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130830 Address after: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant after: Hangzhou Zhongying Technology Group Co., Ltd. Address before: Hangzhou City, Zhejiang province 310000 Binjiang District West Street (pro) Chutian Road No. 88 Applicant before: Zhejiang Zhongying Life Ark Biological Engineering Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151230 Address after: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant after: Hangzhou Zhongying bio-medical technology limited company Address before: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant before: Hangzhou Zhongying Technology Group Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |